74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
OPKO Health Inc
Closed
Sector Healthcare
1.67
Overview
Share price change
24h
Min
1.67
Max
1.68
Income | 35M 25M |
|---|---|
Sales | -8.6M 174M |
EPS | -0.03 |
Profit margin | 14.335 |
Employees | 3,930 |
EBITDA | 68M 90M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +78.57 upside |
Next Earnings | 27 Feb 2025 |
|---|
Market Cap | -2.6B 1.2B |
|---|---|
Previous open | 1.67 |
Previous close | 1.67 |
News Sentiment
By Acuity
53%
47%
311 / 393 Healthcare
OPKO Health Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
OPKO Health Inc Forecast
Price Target
By TipRanks
78.57% upside
12 Months Forecast
Average 3 USD 78.57%
High 3 USD
Low 3 USD
Based on 2 Wall Street analysts offering 12 month price targets forOPKO Health Inc - Dist in the last 3 months.
Sentiment
By Acuity
311 / 393 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About OPKO Health Inc
OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.
